Intersect ENT

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch Intersect ENT and buy or sell other stocks, options, and ETFs commission-free!

About XENT

Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose, and Throat surgeons to utilize in providing improved treatment for their patients. 

CEO
Thomas A. West, MBA
CEOThomas A. West, MBA
Employees
433
Employees433
Headquarters
Menlo Park, California
HeadquartersMenlo Park, California
Founded
2003
Founded2003
Employees
433
Employees433

XENT Key Statistics

Market cap
954.79M
Market cap954.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
733.84K
Average volume733.84K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$28.25
52 Week high$28.25
52 Week low
$15.92
52 Week low$15.92

XENT Earnings

-$1.27
-$0.85
-$0.42
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 7, After Hours
ActualExpected Mar 7, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.